Abstract
Epidermal Growth Factor (EGF) is a mitogenic peptide that binds to surface membrane receptors (EGFR) of breast cancer cells. After binding, secondary transmitter molecules are activated by tyrosine phosphorylation of the intracellular receptor domaine. The activity of the EGF/EGFR system can be modulated by a variety of chemically unrelated compounds including cytostatic agents. The purpose of our present study was to determine the effects of vinorelbine, a novel semisynthetic vinca alkaloid on EGF receptor binding on human breast cancer cells. We have found that MDA-231 and MDA-468 cells bind substantially more [125I]-EGF after preincubation with vinorelbine. This effect was concentration- and time-dependent reaching a maximum at 100 ng/ml and 24 h incubation. Subsequent experiments showed an increase in the rate of EGF binding as well as maximal binding capacity. Scatchard analysis of binding experiments under equilibrium conditions indicated that this was mainly due to an increase in the number of apparent EGF binding sites. Modulation of EGF receptor binding by vinorelbine was not detectable when isolated membranes were used indicating that intact cytoplasmatic mechanisms are required for the upregulation of EGF receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hanauske A-R, Osborne CK, Chamness GC, Clark GM, Forseth BJ, Buchok JB, Arteaga CL, Von Hoff DD: Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents. Eur J Cancer Clin Oncol 23:545–551, 1987
Zuckier G, Tritton TR: Adriamycin causes upregulation of epidermal growth factor receptors in actively growing cells. Exp Cell Res 148:155–161, 1983
Hanauske A-R, Trijssenaar J, Hanauske HM, Szamel MM, Depenbrock H, Freund M, Poliwoda H: Differential effects of anthracycline on growth factor binding to breast cancer cells. J Cell Pharmacol 1:86–94, 1990
Eckel J, Reinauer H: Effect of vinblastine on the insulinreceptor interaction on mammalian heart muscle. Biochem Biophys Res Commun 92:1403–1408, 1980
Meyers MB, Merluzzi VJ, Spengler BA, Biedler JL: Epidermal growth factor receptor is increased in multidrugresistant Chinese hamster and mouse tumor cells. Proc Natl Acad Science USA 83:5521–5525, 1986
Meyers MB, Shen WP, Spengler BA, Ciccarone V, O'Brien JP, Donner DB, Furth ME, Biedler JL: Increased epidermal growth factor receptor in multidrugresistant human neuroblastoma cells. J Cell Biol 38:87–97, 1988
Osborne CK, Hamilton B, Nover M: Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metabol 55:86–93, 1982
Perez R, Pascual M, Macias A, Lage A: Epidermal growth factor receptors in human breast cancer. Breast Cancer Res Treatm 4:189–193, 1984
Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, Tahara E: Expression of epidermal growth factor receptor in human gastric and colonic carcinoma. Cancer Res 48: 137–141, 1988
Hendler FJ, Ozanne BW: Human squamous cell lung carcinoma express increased epidermal growth factor receptors. J Clin Invest 74:657–651, 1984
Sargent ER, Gomella LG, Belldegrun A, Linehan WM, Kasid A: Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. J Urol142:1364–1368, 1989
Budillon A, Tagliaferri P, Caraglia M, Torrisi MR, Normanno N, Iacobelli S, Palmieri G, Stoppelli MP, Frati E, Bianco AR: Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells. Cancer Res 51:1294–1299, 1991
Eisenkraft BL, Nanus DM, Albino AP, Pfeffer EM: α-Interferon down-regulates epidermal growth factor receptor on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of α-interferon. Cancer Res 51:5881–5887, 1991
Zoon KC, Karasaki Y, Zur Nedden DE, Hu R, Arnheiter H: Modulation of epidermal growth factor receptors by human α-interferon. Proc Natl Acad Science USA 83: 8226–8230, 1986
Wrann M, Fox CF, Ross R: Modulation of epidermal growth factor receptors on 3T3 cells by platelet-derived growth factor. Science 210:1363–1364, 1980
Zachary I, Sinnett-Smith JW, Rozengurt E: Early events elicited by bombesin and structurally related peptides in quiescent swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol 102:2211–2222, 1986
Lazarovici P, Dickens G, Kuzuya H, Guroff G: Longterm, heterologous down-regulation of the epidermal growth factor receptor in PC 12 cells by nerve growth factor. J Cell Biol 104:1611–1621, 1987
Jaken S, Tashijan AR Jr, Blumberg PM: Relationship between biological responsiveness to phorbol esters and receptor levels in GH4C1 rat pituitary cells. Cancer Res 41:4956–4960, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Depenbrock, H., Shirvani, A., Rastetter, J. et al. Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell linesin vitro . Invest New Drugs 13, 187–193 (1995). https://doi.org/10.1007/BF00873799
Issue Date:
DOI: https://doi.org/10.1007/BF00873799